Bicycle Therapeutics plc (BCYC)
NASDAQ: BCYC · Real-Time Price · USD
4.350
+0.170 (4.07%)
Jul 10, 2026, 2:20 PM EDT - Market open

Bicycle Therapeutics Revenue

Bicycle Therapeutics had revenue of $887.00K in the quarter ending March 31, 2026, a decrease of -91.11%. This brings the company's revenue in the last twelve months to $63.50M, up 146.85% year-over-year. In the year 2025, Bicycle Therapeutics had annual revenue of $72.59M with 105.77% growth.

Revenue (ttm)
$63.50M
Revenue Growth
+146.85%
P/S Ratio
4.60
Revenue / Employee
$220,472
Employees
288
Market Cap
303.68M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202572.59M37.31M105.77%
Dec 31, 202435.28M8.30M30.76%
Dec 31, 202326.98M12.51M86.52%
Dec 31, 202214.46M2.77M23.65%
Dec 31, 202111.70M1.31M12.58%
Dec 31, 202010.39M-3.41M-24.72%
Dec 31, 201913.80M6.67M93.40%
Dec 31, 20187.14M5.08M246.41%
Dec 31, 20172.06M--
Dec 31, 20160--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
MacroGenics157.08M
Niagen Bioscience130.42M
Surrozen7.49M
Cartesian Therapeutics1.78M
SAB Biotherapeutics114.70K
InflaRx33.82K
Revenue Rankings